Review article · 2025 · Open access

Metformin—mechanisms of its glycemia-reducing effect

Jürgen Drewe, Marc Foretz, Stephan Krähenbühl

Pharmacological Reviews, 78(1), 100106 · Published 21 November 2025 · DOI 10.1016/j.pharmr.2025.100106

Open full textView at the publisherCite this paper

In brief

“Metformin—mechanisms of its glycemia-reducing effect” is a 2025 review article by Jürgen Drewe and 2 co-authors, published in Pharmacological Reviews. OpenAlex counts 19 citations as of 17 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access: the full text is free to read at HAL.

Citations
19
Most cited in
2026 (19)
Field-weighted impact
1.34
References
393
Authors
3

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Drewe, J., Foretz, M., & Krähenbühl, S. (2025). Metformin—mechanisms of its glycemia-reducing effect. Pharmacological Reviews, 78(1), 100106. https://doi.org/10.1016/j.pharmr.2025.100106

MLA 9

Drewe, Jürgen, et al. “Metformin—mechanisms of its glycemia-reducing effect.” Pharmacological Reviews, vol. 78, no. 1, 2025, p. 100106. https://doi.org/10.1016/j.pharmr.2025.100106.

Chicago

Drewe, Jürgen, Marc Foretz, and Stephan Krähenbühl. 2025. “Metformin—mechanisms of its glycemia-reducing effect.” Pharmacological Reviews 78 (1): 100106. https://doi.org/10.1016/j.pharmr.2025.100106.

Harvard

Drewe, J., Foretz, M. and Krähenbühl, S. (2025) ‘Metformin—mechanisms of its glycemia-reducing effect’, Pharmacological Reviews, 78(1), p. 100106. doi:10.1016/j.pharmr.2025.100106.

IEEE

J. Drewe, M. Foretz, and S. Krähenbühl, “Metformin—mechanisms of its glycemia-reducing effect,” Pharmacological Reviews, vol. 78, no. 1, p. 100106, 2025, doi: 10.1016/j.pharmr.2025.100106.

BibTeX

@article{drewe2025metformin,
  title     = {{Metformin—mechanisms of its glycemia-reducing effect}},
  author    = {Drewe, Jürgen and Foretz, Marc and Krähenbühl, Stephan},
  journal   = {Pharmacological Reviews},
  year      = {2025},
  volume    = {78},
  number    = {1},
  pages     = {100106},
  doi       = {10.1016/j.pharmr.2025.100106},
  url       = {https://doi.org/10.1016/j.pharmr.2025.100106}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer

  • metformin
  • type 2 diabetes
  • AMPK
  • mitochondrial complex I inhibition
  • hepatic gluconeogenesis
  • intestinal glucose absorption
  • glucagon-like peptide-1
  • gut microbiota

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Drewe, J., Foretz, M., & Krähenbühl, S. (2025). Metformin—mechanisms of its glycemia-reducing effect. Pharmacological Reviews, 78(1), 100106. https://doi.org/10.1016/j.pharmr.2025.100106

How many times has this paper been cited?

19 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at HAL: sign in and open the full text from this page.

Who wrote this paper?

Jürgen Drewe, Marc Foretz, Stephan Krähenbühl.

What is the DOI of this paper?

10.1016/j.pharmr.2025.100106, permanently at https://doi.org/10.1016/j.pharmr.2025.100106. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.